1 dividend stock I’d buy for under £1

Not all penny shares involve taking big risks. Paul Summers reveals a dividend stock he’d be comfortable snapping up now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Penny stocks tend to be all about the potential for huge capital growth. Think risky oil plays or binary bet biotech firms.

Today however, I’m looking at a sub-£1 share whose main draw, at least for me, is its income stream. In fact, I think this dividend stock could quite easily be a core holding if securing a lifetime of passive income were my priority.

Defensive income

The stock — or real estate investment trust (REIT) to be completely accurate — is Assura (LSE: AGR). No, I hadn’t heard of it either.

To bring everyone up to speed, the FTSE 250 member owns, develops and manages medical centres for GPs. There are several reasons why this strikes me as an attractive destination for my money.

First, there’s the demand. It’s hard to imagine a more defensive sector in the market than healthcare. This quality has become even more apparent following the pandemic and the push to have more community-based services.

A consequence of this is that Assura has great visibility on earnings. Leases tend to be 21+ years. It’s also able to pre-let properties before they are even constructed.

All this has been good news for income hunters. With the exception of the anomaly that was 2020, Assura has a great record hiking its total payout. For me, that’s preferable to a company offering sky-high cash returns only for these to prove unsustainable and eventually cut.

So just how good are the dividends?

Analysts are predicting Assura will return 3.11p per share to holders in FY23 (which began on 1 April). Using Friday’s closing price, that’s a yield of 4.6%.

That may not be the highest I can find, but it still sounds pretty good to me. It’s slightly above that of peer Primary Health Properties (4.4%) and significantly greater than the FTSE 250 index as a whole (2.4%).

It goes without saying that 4.6% is also an awful lot more than I’d get from any kind of cash savings account. With inflation showing no sign of slowing, the value of my money is literally being eroded if I went for this option. No thanks.

Risks to consider

Of course, no investment is risk-free. Say what you like about cash savings (and I do), having at least some money on hand for life’s little emergencies (or just ridiculously high energy costs) is never a bad plan. I also know that my bank balance won’t jump around as the UK stock market has recently.

An investment in Assura carries no such guarantee. As evidence, the share price is down 7% in the last 12 months. Sure, some penny stocks have fared far worse. But there’s no rule to say it can’t fall further.

Then there’s the valuation. A forecast P/E of 21 is on the expensive side for an income stream that, while looking solid, can never be guaranteed.

Core holding

On balance, I’d be prepared to buy this dividend stock today. It ticks the vast majority of boxes on my checklist for a long-term income play.

And if I choose to reinvest what I receive, I stand to benefit even more from the magic that is compounding. How very Foolish.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has recommended Primary Health Properties. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »